Lilly Sets Dates and Conference Calls for 2014 Financial Guidance and Fourth-Quarter 2013 Financial Results Announcements

INDIANAPOLIS, Jan. 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2014 on Tuesday, January 7, 2014 and, separately, will announce its financial results for the fourth quarter and full year of 2013 on Thursday, January 30, 2014.  On each day, Lilly will also conduct conference calls with the investment community and media to further detail the company's 2014 financial guidance and its 2013 financial performance, respectively.

The conference calls on both days will begin at 9:00 a.m. EST.  Investors, media and the general public can access live webcasts of the conference calls through links that will be posted on Lilly's website at www.lilly.com.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY




Refer to:  


(317) 276-5795 – Mark Taylor (media)



(317) 655-6874 – Phil Johnson (investors)




(Logo:  http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

SOURCE Eli Lilly and Company

Suggested Articles

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.

Amid a tough fight in the blood thinner market, J&J and Bayer's Xarelto scored a trial win in treating PAD patients after a recent leg artery surgery.

Experts say it's worth exploring whether a Roche stroke drug could help certain COVID-19 patients.